Robots are helping doctors remove prostates, deliver anesthetics and intubate sedated patients. Now, they might help them place stents.

Royal Philips Electronics said Thursday it bought a minority stake in privately held Corindus Vascular Robotics, a startup that makes an experimental robot for placing stents, balloon catheters and coronary guidewires. The Dutch electronics giant did not disclose terms of the deal.

While stents and X-ray machines have advanced in the past three decades, "the procedural process itself has remained largely unchanged," said David Handler, president and CEO of the Natick, Mass.-based Corindus, in a statement.
His company hopes his new device, the CorPath 200 System, changes all that. The system lets the doctor sit in a cockpit and remotely control a stent-placing robot. In its marketing materials, Corindus says the system might be able to improve visualization and minimize physician fatigue. Corindus also expects the lead-lined cockpit will reduce the doctor's exposure to radiation during interventional procedures.

The company hopes to wrap up its CorPath PRECISE trial, which just enrolled its first patients, in July. The Phase II trial, expected to enroll 175 patients by the end, will be the basis for the company's Food and Drug Administration 510(k) application. According to information filed with clinicaltrials.gov, the trial looks to see how safely the device can perform percutaneous coronary intervention procedures and whether it can reduce radiation exposure to the operator.

More Industry Headlines